| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |